glutathione drug release responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology Liposomal Glutathione Softgels, Enhanced Absorption
Description
"These statements have not been evaluated by the Food and Drug Administration
The spectra of the IS and the SEI are displayed in Figure 1
The evidence for this is provided by evaluating the liver function biomarkers, CYP2E1 gene expression, iron overload, oxidative stress, SIRT-1 expression and hepatic architecture damage associated with APAP overdose
Her research was funded by independent grants to her from the Medical Research Council of Canada, the National Cancer Institute of Canada and the National Institutes of Health in the United States
PMID: 36234817 Quispe, C
